The United States Cataract Atlas provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The Cataract Atlas offers strategic insights into the top potential markets in the US.

The United States Glaucoma Atlas provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis analyzes market potential and provides a benchmark against other atlas metros. The Glaucoma Atlas offers strategic insights into the top potential markets in the US.

The 2020 Glaucoma Pharmaceuticals Market Report is Market Scope’s comprehensive analysis of the glaucoma pharmaceutical segment of ophthalmology. Our report is designed for members of the ophthalmic industry who participate in this market or are weighing doing so, market analysts, ophthalmologists who treat glaucoma patients, investors, and anyone else who might be interested in the global marketplace of glaucoma pharmaceuticals.

The 2020 Retinal Surgical Device Market Report provides in-depth analysis of the global retinal device market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2020 market and forecasts market growth and evolution through 2025.

The 2019 Refractive Surgery Market Report analyzes the global refractive and presbyopia-correcting market, identifying important trends and key factors for future success. It focuses on the 2019 refractive and presbyopia-correcting surgical market and forecasts market growth and evolution over the next five years. Included are discussions and market estimates for LASIK, lenticular extraction, phakic IOLs, corneal inlays, refractive lens exchange (RLE), lenticule extraction, and other technologies that may disrupt the market.

Market Scope’s 2019 European Five Ophthalmic Market Report analyzes the ophthalmic market in Europe’s five largest economies, discussing important trends and key factors for future success in nine ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles companies in ophthalmic markets in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.

The report offers a comprehensive analysis of the 2019 global market for surgical instruments—both reusable and disposable—and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery.  

Hip arthroplasty—including primary THA, revision THA, and hemiarthroplasty—is a major revenue component of the orthopedic market. Global demand for these procedures is rising alongside expanding elderly population segments and increased access to care in historically underserved countries. New technology and innovative implant designs promise to shift the cost-benefit ratio of the procedures, which coincides with pressure from global health care system to decrease costs.

This report provides an in-depth analysis of the global hip arthroplasty market with forecasts through 2024. It is designed for manufacturers, providers, market analysts, and investors who are interested in the hip arthroplasty market and related products.

This report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market. The information covers investments in ophthalmic ventures in 2018 and the first 10 months of 2019, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings.

The primary purpose of this report is to analyze investments in ophthalmology and provide information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

The interbody device market is estimated to be the largest segment of the overall spine surgery market. However, market share is expected to wane as alternatives to fusion improve and the cost of implants decreases.

Fusion procedure counts are expected to increase as the global population ages and access to medical care improves. Development of non-surgical and surgical alternatives such as artificial disc replacement will compete with these upward market trends. We estimate that the interbody device market will grow, but at a low single-digit CAGR.

This report is designed for manufacturers, market analysts, providers, and investors who are interested in the spine surgery business and interbody devices, specifically. The primary purpose of this report is to analyze the interbody device segment of the spine surgery market, identifying important trends and key factors for future success.